Tunable drug release profiles from salicylate-based poly(anhydride-ester) matrices using small molecule admixtures

Journal of Bioactive and Compatible Polymers

Volumn 27, Issue 6, 2012, Pages 540-549

  Ouimet, Michelle A ^a   Snyder, Sabrina S ^b   Uhrich, Kathryn E ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Biodegradable; drug delivery; poly(anhydride ester); polymer; salicylic acid; salicylic acid prodrugs; sustained release; timed release

Indexed keywords

BIODEGRADABLE; POLY(ANHYDRIDE-ESTER); PRODRUGS; SALICYLIC ACIDS; SUSTAINED RELEASE; TIMED RELEASE;

BIODEGRADABLE POLYMERS; DRUG DELIVERY; DRUG PRODUCTS; ESTERS; LOADING; MOLECULES; POLYMERS;

ESTERIFICATION;

ACID ANHYDRIDE; DRUG CARRIER; POLY(ANHYDRIDE ESTER); SALICYLIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG MIXTURE; DRUG RELEASE; GLASS TRANSITION TEMPERATURE;

EID: 84869034930     PISSN: 08839115     EISSN: 15308030     Source Type: Journal    
DOI: 10.1177/0883911512464605     Document Type: Article

References (40)

1. Wu KK. Aspirin and salicylate: an old remedy with a new twist. Circulation. 2000 ; 102 (17). 2022-2023
2. Roseborough IE, Grevious MA, Lee RC. Prevention and treatment of excessive dermal scarring. J Natl Med Assoc. 2004 ; 96 (1). 108-116
3. Rumore MM, Kim KS. Potential role of salicylates in type 2 diabetes. Ann Pharmacother. 2010 ; 44 (7-8). 1207-1221
4. Yamazaki R, Kusunoki N, Matsuzaki T, et al. Aspirin and sodium salicylate inhibit proliferation and induce apoptosis in rheumatoid synovial cells. J Pharm Pharmacol. 2002 ; 54 (12). 1675-1679
5. Perugini RA, McDade TP, Vittimberga FJ, et al. Sodium salicylate inhibits proliferation and induces G1 cell cycle arrest in human pancreatic cancer cell lines. J Gastrointest Surg. 2000 ; 4 (1). 24-32
6. Spitz GA, Furtado CM, Sola-Penna M, et al. Acetylsalicylic acid and salicylic acid decrease tumor cell viability and glucose metabolism modulating 6-phosphofructo-1-kinase structure and activity. Biochem Pharmacol. 2009 ; 77 (1). 46-53
7. Uhrich KE, Cannizzaro SM, Langer RS, et al. Polymeric systems for controlled drug release. Chem Rev. 1999 ; 99 (11). 3181-3198
8. Amann R, Peskar BA. Anti-inflammatory effects of aspirin and sodium salicylate. Eur J Pharmacol. 2002 ; 447 (1). 1-9
9. Domb AJ. Polymeric carriers for regional drug therapy. Mol Med Today. 1995 ; 1 (3). 134-139
10. Jain JP, Modi S, Domb AJ, et al. Role of polyanhydrides as localized drug carriers. J Control Release. 2005 ; 103 (3). 541-563
11. Tang Y, Singh J. Controlled delivery of aspirin: effect of aspirin on polymer degradation and in vitro release from PLGA based phase sensitive systems. Int J Pharm. 2008 ; 357 (1-2). 119-125
12. Tada D, Tanabe T, Tachibana A, et al. Drug release from hydrogel containing albumin as crosslinker. J Biosci Bioeng. 2005 ; 100 (5). 551-555
13. Hu Y, Zhou X, Lu Y, et al. Novel biodegradable hydrogels based on pachyman and its derivatives for drug delivery. Int J Pharm. 2009 ; 371 (1-2). 89-98
14. Wenk E, Wandrey AJ, Merkle HP, et al. Silk fibroin spheres as a platform for controlled drug delivery. J Control Release. 2008 ; 132 (1). 26-34
15. Wang Q, Zhang N, Hu X, et al. Chitosan/polyethylene glycol blend fibers and their properties for drug controlled release. J Biomed Mater Res A. 2008 ; 85 (4). 881-887
16. Huang X, Brazel CS. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J Control Release. 2001 ; 73 (2-3). 121-136
17. Schmeltzer RC, Johnson M, Griffin J, et al. Comparison of salicylate-based poly(anhydride-esters) formed via melt-condensation versus solution polymerization. J Biomater Sci Polym Ed. 2008 ; 19 (10). 1295-1306
18. Griffin J, Delgado-Rivera R, Meiners S, et al. Salicylic acid-derived poly(anhydride-ester) electrospun fibers designed for regenerating the peripheral nervous system. J Biomed Mater Res A. 2011 ; 97 (3). 230-242
19. Erdmann L, Macedo B, Uhrich KE. Degradable poly(anhydride ester) implants: effects of localized salicylic acid release on bone. Biomaterials. 2000 ; 21 (24). 2507-2512
20. Harten RD, Svach DJ, Schmeltzer R, et al. Salicylic acid-derived poly(anhydride-esters) inhibit bone resorption and formation in vivo. J Biomed Mater Res A. 2005 ; 72 (4). 354-362
21. Reynolds MA, Prudencio A, Aichelmann-Reidy ME, et al. Non-steroidal anti-inflammatory drug (NSAID)-derived poly(anhydride-esters) in bone and periodontal regeneration. Curr Drug Deliv. 2007 ; 4 (3). 233-239
22. Carbone AL, Uhrich KE. Design and synthesis of fast-degrading poly(anhydride-esters). Macromol Rapid Commun. 2009 1021 ; 30 ( 12 ):
23. Prudencio A, Schmeltzer RC, Uhrich KE. Effect of linker structure on salicylic acid-derived poly(anhydride-esters). Macromolecules. 2005 ; 38 (16). 6895-6901
24. Johnson ML, Uhrich KE. Concurrent release of admixed antimicrobials and salicylic acid from salicylate-based poly(anhydride-esters). J Biomed Mater Res A. 2009 ; 91 (3). 671-678
25. Vogel B. Synthesis of novel biodegradable polyanhydrides containing aromatic and glycol functionality for tailoring of hydrophilicity in controlled drug delivery devices. Biomaterials. 2005 ; 26 (7). 721-728
26. Torres MP, Vogel BM, Narasimhan B, et al. Synthesis and characterization of novel polyanhydrides with tailored erosion mechanisms. J Biomed Mater Res A. 2006 ; 76 (1). 102-110
27. Mountziaris PM, Mikos AG. Modulation of the inflammatory response for enhanced bone tissue regeneration. Tissue Eng Part B Rev. 2008 ; 14 (2). 179-186
28. Simon AM, O'Connor JP. Dose and time-dependent effects of cyclooxygenase-2 inhibition on fracture-healing. J Bone Joint Surg Am. 2007 ; 89 (3). 500-511
29. Gonzalez-Rodriguez ML, Perez-Martinez JI, Merino S, et al. Channeling agent and drug release from a central core matrix tablet. Drug Dev Ind Pharm. 2001 ; 27 (5). 439-446
30. Shen E, Kipper MJ, Dziadul B, et al. Mechanistic relationships between polymer microstructure and drug release kinetics in bioerodible polyanhydrides. J Control Release. 2002 ; 82 (1). 115-125
31. Sibambo SR, Pillay V, Choonara YE, et al. A novel salted-out and subsequently crosslinked poly(lactic-co-glycolic acid) polymeric scaffold applied to monolithic drug delivery. J Bioact Compat Polym. 2008 ; 23 (2). 132-153
32. Kishida A, Goto H, Murakami K, et al. Synthesis and 5-fluorouracil release profiles of biodegradable polymeric prodrugs γ-poly(hydroxymethyl- 5-fluorouracil-glutamate). J Bioact Compat Polym. 1998 ; 13 (3). 222-233
33. Kim JM, Seo KS, Jeong YK, et al. Co-effect of aqueous solubility of drugs and glycolide monomer on in vitro release rates from poly(D.L-lactide-co- glycolide) discs and polymer degradation. J Biomater Sci Polym Ed. 2005 ; 16 (8). 991-1007
34. Yoo JY, Kim JM, Khang G, et al. Effect of lactide/glycolide monomers on release behaviors of gentamicin sulfate-loaded PLGA discs. Int J Pharm. 2004 ; 276 (1-2). 1-9
35. Erdmann L, Uhrich KE. Synthesis and degradation characteristics of salicylic acid-derived poly(anhydride-esters). Biomaterials. 2000 ; 21 (19). 1941-1946
36. Schmeltzer RC, Schmalenberg KE, Uhrich KE. Synthesis and cytotoxicity of salicylate-based poly(anhydride esters). Biomacromolecules. 2005 ; 6 (1). 359-367
37. Göpferich A, Tessmar J. Polyanhydride degradation and erosion. Adv Drug Deliv Rev. 2002 ; 54 (7). 911-931
38. Akbari H, D'Emanuele A, Attwood D. Effect of geometry on the erosion characteristics of polyanhydride matrices. Int J Pharm. 1998 ; 160 (1). 83-89
39. Siepmann F, Le Brun V, Siepmann J. Drugs acting as plasticizers in polymeric systems: a quantitative treatment. J Control Release. 2006 ; 115 (3). 298-306
40. Whitaker-Brothers K, Uhrich K. Investigation into the erosion mechanism of salicylate-based poly(anhydride-esters). J Biomed Mater Res A. 2006 ; 76 (3). 470-479